These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13219561)

  • 21. [Lupus erythematosus and synthetic antimalarials; personal experience with nivaquine, and its advantages over quinacrine, based on 36 cases].
    GRUPPER C
    Bull Soc Fr Dermatol Syphiligr; 1953; 60(5):423-8. PubMed ID: 13150041
    [No Abstract]   [Full Text] [Related]  

  • 22. [Resochin (aralen, nivaquine) in the treatment of lupus erythematosus & other skin diseases].
    POPOV L; POPKHRISPOV P; BOTEV ShT; BAZHDEKOV B; GRIGOROV I; KHLEBAROV S
    Suvr Med (Sofiia); 1958; 9(9):3-16. PubMed ID: 13615652
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative data and remote results in therapy of lupus erythematosus with resochin, aminoquinol and other substances].
    DMITRIEVA IN; BELUKHA UK
    Vestn Dermatol Venerol; 1962 Jan; 36():23-30. PubMed ID: 13886713
    [No Abstract]   [Full Text] [Related]  

  • 24. Amodiaquin (camoquin) in the treatment of lupus erythematosus.
    BIAGINI DF; CAPURRO ET; SANCHEZ CABALLERO HJ; BOSQ P; ARAMBURU N
    Antibiotic Med Clin Ther (New York); 1957 Nov; 4(11):700-2. PubMed ID: 13488410
    [No Abstract]   [Full Text] [Related]  

  • 25. [Present day treatment of lupus erythematosus].
    GRUPPER C
    Gaz Med Fr; 1955 Oct; 62(20):1393-403. PubMed ID: 13294335
    [No Abstract]   [Full Text] [Related]  

  • 26. [Management of systemic lupus erythematosus (LED) and related diseases].
    Munthe E
    Tidsskr Nor Laegeforen; 1973 Mar; 93(8):533-6. PubMed ID: 4697597
    [No Abstract]   [Full Text] [Related]  

  • 27. [Is lupus erythematosus a type of toxicoderma or an inflammation; synthetic antimalarials seen as antiphologistic therapy].
    JUSTER E
    Bull Soc Fr Dermatol Syphiligr; 1955; (5):505-7. PubMed ID: 13316367
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results and method of treatment by nivaquine in dermatology].
    THIERS H; COLOMB D; PELLOUX H
    J Med Lyon; 1959 Nov; 40():881-6. PubMed ID: 13837814
    [No Abstract]   [Full Text] [Related]  

  • 29. [Present status of the treatment of disseminated lupus erythematosus. I. Antimalarial drugs].
    DYK T
    Pol Arch Med Wewn; 1958; 28(6):939-46. PubMed ID: 13601356
    [No Abstract]   [Full Text] [Related]  

  • 30. [Favorable results of camoquin therapy of exanthematous lupus erythematosus].
    NONCLERCQ E; PETIT JC
    Bull Soc Fr Dermatol Syphiligr; 1955; (4):385-7. PubMed ID: 13284500
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current works on lupus erythematosus therapy].
    ROUQUES L
    Presse Med (1893); 1954 Nov; 62(75):1556-7. PubMed ID: 13215447
    [No Abstract]   [Full Text] [Related]  

  • 32. Observations on the course and treatment of systemic lupus erythematosus.
    ZIFF M; ESSERMAN P; McEWEN C
    Arthritis Rheum; 1958 Aug; 1(4):332-50. PubMed ID: 13560345
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic efficacy of chloroquine apart from its antimalarial properties].
    GIOSEFFI G
    Boll Chim Farm; 1954 Aug; 93(8):284-92. PubMed ID: 13219227
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antimalarials in therapy of lupus erythematosis].
    FOSS MH
    Tidsskr Nor Laegeforen; 1957 Apr; 77(8):341-4. PubMed ID: 13433699
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lupus erythematosus developing for seven years improved by the combination of a synthetic antimalarial (premaline) with mild cryotherapy].
    MIRCOUCHE I; JUSTER E
    Bull Soc Fr Dermatol Syphiligr; 1954; 61(4):319-20. PubMed ID: 13219542
    [No Abstract]   [Full Text] [Related]  

  • 36. Antimalarials and cholesterol profile of patients with systemic lupus erythematosus.
    Rossoni C; Bisi MC; Keiserman MW; Staub HL
    Rev Bras Reumatol; 2011; 51(4):383-4, 386-7. PubMed ID: 21779713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
    Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
    Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lupus erythematosus. 5. Current status and trends in therapy of lupus erythematosus: a) S.L.E.: therapy with antimalarials, steroid therapy and monitoring, acupuncture; b) D.L.E.; c) Therapy of oral lesions and xerostomia; d) Dental treatment during L.E].
    Frojo M; Palomba F; Rullo R
    Arch Stomatol (Napoli); 1989 Nov; 30(5):1113-25. PubMed ID: 2641870
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute lupus erythematosus; treatment with nivaquine alone; first case].
    GRUPPER C
    Bull Mem Soc Med Hop Paris; 1954 Nov 19-26; 70(30-31):1111-7. PubMed ID: 14364247
    [No Abstract]   [Full Text] [Related]  

  • 40. Lupus erythematosus treated with a combination of quinacrine, hydroxychloroquine and chloroquine.
    TYE MJ; WHITE H; APPEL B; ANSELL HB
    N Engl J Med; 1959 Jan; 260(2):63-6. PubMed ID: 13613503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.